Pioneered by Mani Menon, M.D., and the Henry Ford Vattikuti Urology Institute, the robotic prostatectomy surgically removes cancer while offering a high probability of preserving sexual function and urinary control. Patients from all 50 states and more than two dozen countries have traveled to have the procedure performed by the world's most experienced team.
Training and experience matter
The Vattikuti Urology Institute has performed more than 5,000 robotic surgeries and counting. More than any other hospital in the world. It is a comprehensive clinical, research and teaching institute that consistently ranks among the best in the nation:
Named a "Best Hospital" for Urology by U.S. News and World Report for 2009
Has dedicated more than $20 million to basic and clinical urology research
The only center in the world offering suicide gene therapy - developed in the Henry Ford Department of Radiation Oncology and currently in Phase III clinical trial - as a way to eliminate prostate cancer cells without damaging surrounding normal tissue
A comprehensive, multidisciplinary approach
Offering some of the world's first and most progressive approaches to treating prostate cancer and other urological conditions, the Vattikuti Urology Institute's surgeons, clinicians and researchers are committed to ensuring the best outcome for each patient. It maintains a database, considered to be the most comprehensive of its kind in the world, of more than 6,000 patients with prostate cancer to determine the most effective therapies.
The Vattikuti Urology Institute is also committed to training the next generation of highly skilled robotic surgeons. Its physicians and fellows helped establish urologic robotic surgery programs at New York-Presbyterian/Weill Cornell, New York-Presbyterian Hospital/Columbia University Medical Center, and Hospital of the University of Pennsylvania, among others. Additionally, each year it hosts the International Robotic Urology Symposium, which attracts physicians from around the world interested in learning robotic surgery from Dr. Menon and his team.
